Improving patients’ access to an important COVID-19 medicine in the region London, United Kingdom, (AETOSWire) – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has entered into a license agreement with Medicine Patent Pool (MPP) for molnupiravir,